Posted on 12/30/2021 9:48:13 AM PST by SeekAndFind
Drug maker Novavax (NVAX) recently revealed a bit of good news that gave the stock an extra 3.4% boost in premarket trading last Thursday. The positive momentum did not last long, as the stock was seen drops approaching 6% in trading Thursday morning. The unexpected fluctuations in trading aside, I'm bullish on Novavax. There are some significant potential expansions ahead, and investors have an excellent opportunity to take advantage of these.
The latest news should be more helpful than the market seems willing to accept. Novavax revealed that its COVID-19 vaccine is effective against the Omicron variant. However, as seems to be increasingly the case, the vaccine's protective capabilities increase if you have recently had a booster shot. Trials show that the vaccine has around a 90.4% efficacy rate, which is good, given the number of variants that keep cropping up. Novavax didn't rule out the possibility of targeted vaccines emerging later, though.
Novavax's CEO, Stanley Erck, pointed out that Novavax's COVID-19 vaccine comes with several advantages that vaccines made via messenger RNA (MRNA) do not. For instance, Novavax's COVID-19 vaccine doesn't require super-cold temperatures, like Pfizer's (PFE) and Moderna's (MRNA) need. This means it's easier to transport and easier to store, and offers better shelf life. Erck also pointed out that the Novavax vaccine has fewer side effects than many of its competitors thanks to a “more benign profile.”
(Excerpt) Read more at nasdaq.com ...
Sure it does.
Yawn…
A bottle of Jack and a wool blanket cures Covid.
I have a bridge for sale.
yep, great news for anyone who wants to be injected with their secret, propriety adjuvant, Matrix-M, a chemical designed to cause your immune system to go bonkers because their vax is so weak it won’t work without something to cause your immune system to hyper-react ... can anyone say: “I wonder if hyper-stimulating my immune system will trigger auto-immune disease or add new ones to my existing auto-immune diseases?”
Omicron will burn out before the vax is available.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.